titles for full stories. See Index
for stories by headline
2 | 3 | 4 | 5
| 6 | Headline
I-Kappa B, New Gene
Switch May soon make radiation and chemotherapy for cancer
more effective, Chapel Hill researchers say.
Toxin Modified to Develop Cancer Drug
The sting of a bee may eventually be used to kill cancer cells. Australian
scientists are modifying bee venom to develop cancer treatments with
fewer side effects than other drugs used to fight the disease.
Some Foods and May Inhibit Cancer-Fighting White Blood Cells
Products from diaper covers to cellophane wrap, dish sponges,
fruit juices, seafood and poultry may contain chemicals that weaken
the immune system, Kentucky researchers say.
Seattle Team Map Gene for Inherited Prostate Cancer Same
gene may be involved in inherited susceptibility to primary brain cancer.
Common Prostate Cancer On/Off Switches Found Nearly 90 percent
of prostate cancers -- "the typical, garden varieties," according
to Johns Hopkins scientists -- are linked to a previously unsuspected
but common genetic process that could be reversible.
Fats May Cut Risk of Prostate Cancer by reducing levels of testosterone
and enzymes that activate it, a new study by University at
Buffalo nutrition researchers suggests.
Care for Prostate Cancer Patients With Terminal Disease Patients
may reach a time when they are faced with a hard choicewhether
to take part in experimental research or enter a hospice. Till now,
choosing one option meant losing benefits of the other. Dr. Kenneth
Pienta is leading a study that adds quality treatment to hospice.
Another Piece of
the Angiogenesis Puzzle -- VEGF A University of Michigan
team has found vascular endothelial growth factor (VEGF) contributes
to angiogenesis not only by stimulating blood vessel growth, but also
by prolonging the survival of blood vessel cells.
Electrical Stimulation May Relieve Pain From Bone Mets, UT Study Finds
Helped patient with prostate cancer, did not help patient without bone
mets. Might be useful combined with other therapies, researchers say.